Asia Pacific Contraceptives Market is estimated to reach $ 6.62 billion by the end of 2021
- Advertising -
The Asia Pacific Contraceptives Market was worth $ 4.73 billion in 2016 and estimated to reach $ 6.62 billion by the end of 2021 with a growing potential of 6.95 %. Regionally, Asia Pacific was highly influencing the industry in terms of demographics and lack of awareness within the large population.
Favourable government initiatives pertaining to sex education of individuals is one of the major factor expected to boost the contraceptives market growth over the forecast period.
Vaginal implants, Male and female condoms, subdermal implants, sponges, IUDs and diaphragms are important devices that accounts for the largest share in the market in terms of revenue.
- Advertising -
This is attributed to growing awareness about STD (Sexually transmitted disease) and the efficiency of condoms to inhibit the infections, including HIV.
Full report at: www.marketdataforecast.com/market-…ives-market-1231/
The Asia – pacific market is driven by growing development of effective female contraceptive devices and drugs, advancement in technologies, increasing initiatives by the government and NGO to promote contraceptives. Restraints the growth of the market are the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility.
Based on drug type the market is segmented into Contraceptive pills, Topical contraceptives, Contraceptive injectable, Others (contraceptive gels, jellies and creams).
Based on medical devices the market is segmented into Male contraceptive devices (Condoms), Female contraceptive devices. Female contraceptive devices are further classified into female condoms, intrauterine devices (Hormonal IUD’s, Copper IUD’s), contraceptive sponges, contraceptive diaphragms, contraceptive patches, subdermal contraceptive implants and non-surgical permanent contraceptive devices.
Based on end users the market is segmented into Hospitals, Home care, Clinics and Ambulatory Surgical Centres.The Asia - Pacific market is analyzed under various regions namely Japan, China, India, and Australia.
Major players operating in Asia - Pacific contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: